The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease

被引:19
|
作者
Bayram, Ece [1 ]
Kaplan, Nikki [2 ]
Shan, Guogen [3 ]
Caldwell, Jessica Z. K. [2 ]
机构
[1] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[2] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA
[3] Univ Nevada, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA
关键词
Parkinson's disease; cognition; mood; striatum; dopamine; POSITRON-EMISSION-TOMOGRAPHY; ANXIETY; SYMPTOMS; AVAILABILITY; PROGRESSION; DEPRESSION; SYSTEM; SPECT;
D O I
10.1080/13825585.2019.1653445
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Cognitive decline and mood symptoms are common in Parkinson's disease (PD). Reductions in striatal dopaminergic binding have been associated with worse cognition and mood. We investigated whether this association persists throughout the disease progression in newly diagnosed PD. Four-year data from Parkinson's Progression Markers Initiative (PPMI) were used. Groups consisted of left and right limb dominantly affected PD patients, and controls. Longitudinal relationships between cognition, mood and striatal binding ratios were assessed by repeated measures correlations. Reduced binding was associated with general cognitive decline in controls, reduced processing speed and increased mood symptoms in PD. Anxiety was associated with striatum only in left limb dominantly affected PD. Dominantly affected limb side did not impact striatum and cognition association. There are longitudinal associations between striatum, processing speed and anxiety. Dopamine transporter availability imaging may have some prognostic value for cognition and mood in PD.
引用
收藏
页码:581 / 594
页数:14
相关论文
共 50 条
  • [41] Impact of regional striatal dopaminergic function on kinematic parameters of Parkinson’s disease
    Myung Jun Lee
    Sha-Lom Kim
    Chul Hyoung Lyoo
    J. O. Rinne
    Myung-Sik Lee
    Journal of Neural Transmission, 2015, 122 : 669 - 677
  • [42] Quantified Striatal Dopaminergic Denervation as a Predictor for Motor Outcomes in Parkinson's Disease
    Trinh, Ilene
    Phielipp, Nicol'as
    MOVEMENT DISORDERS, 2022, 37 : S34 - S35
  • [43] Physical activity mediates the association between striatal dopamine transporter availability and cognition in Parkinson's disease
    Shih, Chia-Hao
    Moore, Kathryn
    Browner, Nina
    Sklerov, Miriam
    Dayan, Eran
    PARKINSONISM & RELATED DISORDERS, 2019, 62 : 68 - 72
  • [44] Clinical biomarkers of striatal dopaminergic denervation in Parkinson disease
    Moore, Robert
    Kuwabara, Hiroto
    Bohnen, Nicolaas
    NEUROLOGY, 2007, 68 (12) : A356 - A356
  • [45] Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson's disease
    Artaud, F.
    Lee, P. C.
    Vidailhet, M.
    Corvol, J. C.
    Elbaz, A.
    MOVEMENT DISORDERS, 2019, 34 : S738 - S738
  • [46] Longitudinal Changes in Cognition in Parkinson's Disease with and without Dementia
    Johnson, David K.
    Galvin, James E.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (02) : 98 - 108
  • [47] Longitudinal course of cognition in elderly women with Parkinson's disease
    Kang, G. A.
    Lui, L.
    Fink, H.
    Miller, B.
    Yaffe, K.
    MOVEMENT DISORDERS, 2012, 27 : S20 - S20
  • [48] Exploring the relation between REM sleep behavior disorder onset and striatal dopaminergic dysfunction in Parkinson's Disease
    Cicero, Calogero Edoardo
    Terravecchia, Claudio
    Tabbi, Silvia
    Garofalo, Rossella
    Luca, Antonina
    Mostile, Giovanni
    Donzuso, Giulia
    Contrafatto, Donatella
    Zappia, Mario
    Nicoletti, Alessandra
    JOURNAL OF NEUROLOGY, 2025, 272 (01)
  • [49] Relationship between nigro-striatal dopaminergic dysfunction and affective symptoms in de novo Parkinson's disease
    Frosini, D.
    Kiferle, L.
    Del Prete, E.
    Vanelli, F.
    Volterrani, D.
    Bonuccelli, U.
    Ceravolo, R.
    JOURNAL OF NEUROLOGY, 2012, 259 : S90 - S91
  • [50] Positive correlation between neuromelanin accumulation in the substantia nigra and striatal dopaminergic innervation in patients with Parkinson's disease
    Marotta, G.
    Isaias, I. U.
    Costa, A.
    Trujillo, P.
    Summers, P.
    Pezzoli, G.
    Benti, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S291 - S292